What to expect
While managing Tyrosinemia Type 1 can be challenging, you should know that you are not alone.
Your healthcare team, made up of your doctor, dietitian, genetic counselors, social workers and other clinicians will help you or your child thrive at every stage of development.
What your physician will do
- Immediately upon diagnosis start therapy with NTBC (e.g., NITYR) and recommend dietary therapy with medical foods and a protein-restricted diet to limit phenylalanine and tyrosine intake while supporting normal growth2
- Monitor health, including growth and body weight, draw blood and collect urine to ensure lab values are within expected bounds2
What your dietitian will do
- Recommend a diet that helps restrict phenylalanine and tyrosine to maintain concentrations within the treatment range2
- Adjust the diet as appropriate as you or your child grows
- Ensure your diet and nutrition supports normal growth and development
Depending on the stage you are at in your journey with Tyrosinemia Type 1, other providers may be added to your healthcare team (e.g., ophthalmologists, neurologists).
How NITYR can help
We understand that a new diagnosis or transitioning to a new medicine may be concerning, but you are not alone. We are here for you to provide continuous support, answer any questions and ensure your NITYR Experience is seamless throughout.
Your healthcare team, made up of your doctor, dietitian, genetic counselors, social workers and other clinicians will help you or your child thrive at every stage of development.
Our product support includes:
- Continuous clinical expertise to help patients and caregivers learn more about NITYR, support navigating insurance requirements, and ensuring timely delivery of prescriptions
- Our Patient Nutrition Program* that reinforces your clinic’s dietary plan with product support that contributes to better outcomes
References
* Patient Nutrition Program: Subject to terms and conditions and eligibility criteria. This program is for patients with a valid prescription for NITYR issued by their physician or other HCP, or commercially insured patients on the 30-Day Free NITYR Program, and is subject to other federal and state law. Terms, conditions and eligibility criteria are available at www.nityr.us/offerstcs.
2. Chinsky JM, Singh R, Ficicioglu C, van Karnebeek CDM, Grompe M, Mitchell G, Waisbren S, Gucsavas-Calikoglu M, Wasserstein MP, Coakley K, Scott CR, Diagnosis and treatment of tyrosinemia type I: a US and Canadian consensus group review and recommendations. Genet Med. 2017 Dec;19(12):1-16. doi: 10.1038/gim.2017.101